ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 176 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 4.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $210,728 | +105.1% | 42,400 | +103.8% | 0.00% | – |
| Q1 2023 | $102,752 | -54.5% | 20,800 | -0.5% | 0.00% | – |
| Q3 2022 | $226,000 | -56.2% | 20,900 | -53.8% | 0.00% | – |
| Q2 2022 | $516,000 | +24.9% | 45,285 | 0.0% | 0.00% | – |
| Q1 2022 | $413,000 | -49.6% | 45,285 | -17.0% | 0.00% | -100.0% |
| Q4 2021 | $819,000 | +99.8% | 54,585 | +241.9% | 0.00% | – |
| Q3 2021 | $410,000 | -1.4% | 15,965 | 0.0% | 0.00% | – |
| Q2 2021 | $416,000 | -38.4% | 15,965 | -10.8% | 0.00% | -100.0% |
| Q3 2020 | $675,000 | -19.4% | 17,895 | -8.4% | 0.00% | 0.0% |
| Q2 2020 | $837,000 | – | 19,538 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $46,213,000 | 13.24% |
| Wildcat Capital Management, LLC | 1,716,370 | $44,111,000 | 5.71% |
| TPG Group Holdings (SBS) Advisors, Inc. | 18,716,306 | $481,009,000 | 4.77% |
| Copernicus Capital Management, LLC | 15,000 | $386,000 | 4.67% |
| Coastal Bridge Advisors, LLC | 301,240 | $7,742,000 | 1.79% |
| Lombard Odier Asset Management (Switzerland) SA | 914,416 | $23,500,000 | 1.46% |
| Casdin Capital, LLC | 2,100,000 | $53,970,000 | 1.34% |
| Pier Capital, LLC | 450,182 | $11,570,000 | 1.20% |
| Ghost Tree Capital, LLC | 150,000 | $3,855,000 | 1.13% |
| Sessa Capital IM, L.P. | 750,000 | $19,275,000 | 0.95% |